Express News | East Bioscience: Obtained Multiple Medical Device Registration Certificates

BreakingsMay 26 15:58

OriGene Biotech (688298.SH): Multiple products have obtained medical device registration certificates.

OriGene Biotech Co., Ltd. (SHA: 688298) announced that the company, along with its wholly owned subsidiary Healgen Scientific LLC (hereinafter referred to as "Healgen USA") and its majority-owned subsidiary Hangzhou Danwei Biotechnology Co., Ltd. (hereinafter referred to as "Hangzhou Danwei"), has recently obtained medical device registration certificates for multiple products.

Zhitong FinanceMay 21 17:57

Company Q&A | Dongfang Bio: Flow fluorescence detection has obtained regulatory approval in both domestic and EU markets, with a primary focus on expanding presence in these regions.

Gelonghui, May 18th | An investor asked Dongfang Biotech on an interactive platform about the company's flow fluorescence (liquid chip) related issues: 1. What is the overall progress of NMPA registration for the company's flow fluorescence instruments and reagents? What are the plans for obtaining certifications during 2026-2028? 2. The period from 2026 to 2028 is considered a window for domestic substitution of flow fluorescence technology. What is the company’s overall domestic market strategy, and what is the approach for channel expansion? What are the specific strategies and timelines for expanding into tertiary hospitals, second- and third-tier cities, as well as county-level hospitals? 3. Which countries and regions are the key overseas markets for flow fluorescence products? What is the status of international certifications?

Gelonghui FinanceMay 18 17:22

Express News | Oriental Biotech: Subsidiary possesses Hantavirus antibody detection reagents, yet to obtain overseas registration certification.

BreakingsMay 8 18:09

Express News | Shift in Virus Prevention and Control Concepts Boosts Daan Gene to Limit Up

BreakingsMay 8 09:55

Express News | The avian flu sector in the A-share market surged in the afternoon session, with Zhongsheng Pharmaceutical hitting the daily price limit. Oriental Biotech, Zhijiang Biotech, Hualan Vaccine, Yiling Pharmaceutical, and Tiankang Biotech also rose in tandem.

BreakingsMay 7 13:06